[et_pb_section fb_built=”1″ _builder_version=”4.25.1″ _module_preset=”default” background_image=”https:\/\/icancme.ca\/wp-content\/uploads\/banner-bg.jpg.webp” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” width=”90%” max_width=”100%” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _dynamic_attributes=”content” _module_preset=”default” text_font=”Montserrat||||||||” text_text_color=”#FFFFFF” text_font_size=”48px” global_colors_info=”{}”]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IiIsImFmdGVyIjoiIiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.25.1″ _module_preset=”default” width=”100%” max_width=”100%” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][dipl_breadcrumb breadcrumb_layout=”layout2″ separator_color=”#0C71C3″ _builder_version=”4.25.1″ _module_preset=”default” global_text_settings_text_align=”center” global_text_settings_font_size=”15px” text_font=”|600||on|||||” text_text_color=”#0C71C3″ background_color=”#FFFFFF” width=”100%” module_alignment=”right” custom_padding=”1vw|1vw|1vw|1vw|true|true” global_colors_info=”{}”][\/dipl_breadcrumb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.27.3″ _module_preset=”default” width=”90%” max_width=”100%” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.27.0″ _module_preset=”default” background_color=”#f0f5f9″ sticky_position=”top” sticky_position_tablet=”none” sticky_position_phone=”none” sticky_position_last_edited=”on|tablet” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.3″ _module_preset=”default” text_text_color=”#FFFFFF” background_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ custom_margin=”||0px|||” custom_padding=”1vw||1vw|2vw|true|false” global_colors_info=”{%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22background_color%22%93}”]<\/p>\n

RESOURCES<\/p>\n

[\/et_pb_text][et_pb_menu menu_id=”217″ active_link_color=”#247a62″ module_class=”lwp-vertical-menu lwp-hide-mobile-menu” _builder_version=”4.27.3″ _module_preset=”default” menu_font=”Montserrat|700|||||||” menu_text_color=”#000000″ menu_font_size=”16px” background_color=”#f0f5f9″ custom_padding=”1vw|2vw|1vw|2vw|true|true” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22active_link_color%22%93}”][\/et_pb_menu][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.3″ _module_preset=”default” header_font=”Merriweather||||||||” header_2_font=”Merriweather||||||||” header_2_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font_size=”30px” global_colors_info=”{%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22header_2_text_color%22%93}”]<\/p>\n

Ressources cliniques<\/h2>\n

Cette section est destin\u00e9e \u00e0 offrir aux g\u00e9n\u00e9ralistes<\/strong> une compilation de renseignements de consultation rapide et facile, pour am\u00e9liorer leur compr\u00e9hension des notions entourant le diagnostic et la prise en charge de l\u2019enc\u00e9phalomy\u00e9lite myalgique et des conditions comorbides, et pour leur fournir des conseils et des outils sur la fa\u00e7on de soutenir les malades dans leurs d\u00e9marches reli\u00e9es aux demandes d\u2019accommodement et aux programmes d\u2019assistance invalidit\u00e9.<\/p>\n

Nous vous invitons \u00e0 la consulter r\u00e9guli\u00e8rement et \u00e0 l\u2019ajouter \u00e0 vos favoris pour y acc\u00e9der facilement au cours d\u2019une consultation.<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.27.3″ _module_preset=”default” header_2_font=”Montserrat|300|||||||” header_2_text_align=”center” header_2_text_color=”gcid-81f9ad88-9858-401f-a912-9ef6823933cf” background_color=”gcid-primary-color” custom_margin=”||0px||false|false” custom_padding=”1vw||1vw||true|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22header_2_text_color%22%93,%22gcid-primary-color%22:%91%22background_color%22%93}”]<\/p>\n

Liens rapides<\/h2>\n

[\/et_pb_text][dipl_button inline_buttons=”on” buttons_alignment=”center” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”|2vw|0px|2vw|false|false” custom_css_main_element=”background: #f0f5f9;” global_colors_info=”{}”][dipl_button_item button_text=”\u00c9l\u00e9ments de base de l\u2019enc\u00e9phalomy\u00e9lite myalgique” button_url=”#understanding” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][dipl_button_item button_text=”Qu\u2019est-ce que l\u2019enc\u00e9phalomy\u00e9lite myalgique ?” button_url=”#what” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][dipl_button_item button_text=”Enc\u00e9phalomy\u00e9lite myalgique \u2013 Diagnostic et prise en charge” button_url=”#ME” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][\/dipl_button][dipl_button inline_buttons=”on” buttons_alignment=”center” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”|2vw|0px|2vw|false|false” custom_css_main_element=”background: #f0f5f9;” global_colors_info=”{}”][dipl_button_item button_text=”Ressources concernant le rythme des activit\u00e9s (\u00ab pacing \u00bb)” button_url=”#pacing” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][dipl_button_item button_text=”Conditions comorbides fr\u00e9quentes \u2013 Diagnostic et prise en charge” button_url=”#comorbidities” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][dipl_button_item button_text=”Consid\u00e9rations particuli\u00e8res” button_url=”#special” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][\/dipl_button][dipl_button inline_buttons=”on” buttons_alignment=”center” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”|2vw|1vw|2vw|false|false” custom_css_main_element=”background: #f0f5f9;” global_colors_info=”{}”][dipl_button_item button_text=”Assistance aux d\u00e9marches reli\u00e9es aux demandes d\u2019accommodement et aux programmes d\u2019assistance invalidit\u00e9” button_url=”#supporting” button_bg_color=”#FFFFFF” button_custom_margin=”|10px||10px|false|true” _builder_version=”4.27.4″ _module_preset=”default” button_text_color=”#000000″ button_font_size=”14px” border_radii=”on|1px|1px|1px|1px” border_width_all=”1px” border_color_all=”#d9e4ec” global_colors_info=”{}”][\/dipl_button_item][\/dipl_button][et_pb_text module_id=”understanding” _builder_version=”4.27.3″ _module_preset=”default” header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{}”]<\/p>\n

\u00c9l\u00e9ments de base de l\u2019enc\u00e9phalomy\u00e9lite myalgique<\/h2>\n

La documentation qui suit constitue une ressource pour comprendre la maladie et ses conditions comorbides.<\/p>\n

Quoiqu\u2019on ne connaisse \u00e0 l\u2019heure actuelle aucun traitement \u00e9tabli pour l\u2019enc\u00e9phalomy\u00e9lite myalgique, il existe cependant de nombreux moyens de venir en aide aux malades qui ont re\u00e7u ce diagnostic.<\/p>\n

Assistance et encouragement dans la gestion efficace du repos et du rythme des activit\u00e9s (\u00ab pacing \u00bb) ; traitement des principaux sympt\u00f4mes et des conditions comorbides ; appui aux d\u00e9marches reli\u00e9es aux demandes d\u2019accommodement et aux programmes d\u2019assistance invalidit\u00e9 : voil\u00e0 des moyens d\u2019am\u00e9liorer grandement leur niveau fonctionnel et leur qualit\u00e9 de vie.<\/p>\n

[\/et_pb_text][et_pb_divider color=”#e2e2e2″ _builder_version=”4.27.3″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”||0px||false|false” global_colors_info=”{}”][\/et_pb_divider][et_pb_text module_id=”what” _builder_version=”4.27.3″ _module_preset=”default” link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″]<\/p>\n

Qu\u2019est-ce que l\u2019enc\u00e9phalomy\u00e9lite myalgique ?<\/h2>\n

L\u2019enc\u00e9phalomy\u00e9lite myalgique, qu\u2019on appelait auparavant \u00ab syndrome de fatigue chronique \u00bb et que l\u2019on d\u00e9signe souvent encore par l\u2019abr\u00e9viation EM\/SFC, est une maladie chronique complexe et multisyst\u00e9mique aux effets d\u00e9vastateurs. Elle peut se pr\u00e9senter \u00e0 l\u2019enfance, \u00e0 l\u2019adolescence ou \u00e0 l\u2019\u00e2ge adulte. <\/p>\n

Il est clairement admis que c\u2019est une maladie gravement invalidante, qui prend ses racines dans des dysfonctionnements qui affectent, parmi beaucoup d\u2019autres, la production de l\u2019\u00e9nergie, le syst\u00e8me immunitaire et le syst\u00e8me nerveux.<\/p>\n

Son apparition est souvent subite, mais elle peut aussi se d\u00e9velopper graduellement, en g\u00e9n\u00e9ral \u00e0 la suite d\u2019une infection virale ou autre. Le virus SARS-CoV-2 (connu sous le nom de COVID-19) est l\u2019exemple le plus r\u00e9cent de ce type de survenue : jusqu\u2019\u00e0 30 % des cas de COVID grave ont d\u00e9bouch\u00e9 sur un syndrome post-COVID-19 (ou COVID-19 de longue dur\u00e9e), 50 % desquels se sont ensuite transform\u00e9s en enc\u00e9phalomy\u00e9lite myalgique. <\/p>\n

Le sympt\u00f4me cardinal de la maladie est le malaise apr\u00e8s effort ou l\u2019exacerbation des sympt\u00f4mes apr\u00e8s effort, c\u2019est-\u00e0-dire une aggravation des sympt\u00f4mes apr\u00e8s un effort physique ou cognitif, qui se manifeste g\u00e9n\u00e9ralement de 24 \u00e0 72 heures apr\u00e8s l\u2019\u00e9v\u00e9nement d\u00e9clencheur. Les malades le d\u00e9crivent souvent comme un \u00ab crash \u00bb, un \u00e9pisode asth\u00e9nique qui peut durer des jours, des semaines, des mois ou m\u00eame plus longtemps. <\/p>\n

Les patients pr\u00e9sentent \u00e9galement toute une s\u00e9rie de sympt\u00f4mes, notamment des sympt\u00f4mes chroniques et s\u00e9v\u00e8res ressemblant \u00e0 ceux de la grippe, tels que des ganglions lymphatiques sensibles ou gonfl\u00e9s, de la fi\u00e8vre, des maux de t\u00eate, des maux de gorge, ainsi que des douleurs chroniques, des sympt\u00f4mes gastro-intestinaux, une sensibilit\u00e9 au son et \u00e0 la lumi\u00e8re.<\/p>\n

Bien que toute maladie puisse coexister avec l\u2019EM, il existe plusieurs comorbidit\u00e9s communes qu\u2019il convient de conna\u00eetre. Il s\u2019agit notamment de la fibromyalgie, du syndrome de tachycardie orthostatique posturale (POTS), de la dysautonomie, du syndrome d\u2019activation mastocytaire (MCAS), des Syndromes d\u2019Ehlers-Danlos (SED) ou SED hypermobile (SEDh), du SIBO, de la gastropar\u00e9sie et du syndrome du c\u00f4lon irritable. <\/p>\n

Quoique la maladie puisse coexister avec n\u2019importe quelle autre, il faut consid\u00e9rer certaines conditions comorbides fr\u00e9quentes : fibromyalgie, STOP, dysautonomie, activation mastocytaire, syndrome d\u2019Ehlers-Danlos courant ou hypermobile, neuropathie des petites fibres, pullulation bact\u00e9rienne dans l\u2019intestin gr\u00eale (PBIG ou SIBO), gastropar\u00e9sie, syndrome du c\u00f4lon ou de l\u2019intestin irritable. <\/p>\n

Le diagnostic est pos\u00e9 \u00e0 l\u2019aide de l\u2019un des crit\u00e8res reconnus. Conform\u00e9ment aux recommandations des National Institutes of Health des \u00c9tats-Unis et aux meilleures pratiques internationales, le R\u00e9seau de recherche ICanCME utilise les et les <\/span>Crit\u00e8res de consensus canadiens (CCC)<\/a> <\/span>et le <\/span>d\u00e9finitions de l\u2019IOM (d\u00e9sormais Academy of Medicine).<\/a> <\/span>d\u00e9finitions.<\/p>\n

[\/et_pb_text][et_pb_divider color=”#e2e2e2″ _builder_version=”4.27.3″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”||0px||false|false” global_colors_info=”{}”][\/et_pb_divider][et_pb_text module_id=”ME” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#000000″ link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” hover_enabled=”0″ global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″ sticky_enabled=”0″]<\/p>\n

Enc\u00e9phalomy\u00e9lite myalgique \u2013 Diagnostic et prise en charge<\/h2>\n

Enc\u00e9phalomy\u00e9lite myalgique \u2013 Diagnostic et prise en charge<\/strong><\/p>\n

\n
• (Traduction) Clinique Mayo \u2013<\/em> Diagnostic et prise en charge de l’EM (2023)<\/a><\/li>\n<\/ul>\n

  Recommandations du Consensus (2021)<\/strong><\/p>\n

  \n
  • \u00c9l\u00e9ments essentiels de diagnostic et de prise en charge<\/em><\/span>\u00a0Mayo Clinic Proceedings – Essentials of Diagnosis and Management (2021)<\/a><\/li>\n<\/ul>\n

    Crit\u00e8res de l\u2019IOM (maintenant National Academy of Medicine) (2015)<\/strong><\/p>\n

    \n
    • Crit\u00e8res de diagnostic de l\u2019IOM (NAM) <\/em>(<\/span>IOM [NAM] Diagnostic Criteria<\/a>)<\/u><\/a><\/li>\n
    • Feuillets publi\u00e9s par les CDC pour le personnel de soin<\/em>\u00a0<\/span>(CDC Handouts for Healthcare Providers<\/a>)<\/u><\/li>\n
    • Guide de l\u2019IOM pour la pratique clinique<\/em>\u00a0<\/span>(IOM Clinicians Guide<\/a>)<\/u><\/li>\n<\/ul>\n

      Crit\u00e8res du consensus canadien (2003)<\/strong><\/p>\n

      \n
      • D\u00e9finition clinique et lignes directrices \u00e0 l\u2019intention des m\u00e9decins<\/u><\/em>\u00a0<\/span>(<\/u>A Clinical Case Definition and Guideline for Medical Practitioners)<\/a><\/li>\n
      • Centre de pratique efficace – Outils pour l’EM, la fibromyalgie et le POTS (2024) de l’Ontario<\/a><\/li>\n<\/ul>\n

        Ressources de la Coalition am\u00e9ricaine de la pratique clinique concernant l\u2019EM\/SFC<\/strong><\/p>\n

        \n
        • Coalition am\u00e9ricaine de la pratique clinique pour l\u2019EM\/SFC \u2013 Diagnostiquer l\u2019EM\/SFC chez les personnes atteintes de COVID-19 de longue dur\u00e9e<\/em>\u00a0<\/span>(<\/span>S. ME\/CFS Clinician Coalition \u2013 Diagnosing ME\/CFS in People with Long COVID<\/a>)<\/span><\/a><\/li>\n
        • Coalition am\u00e9ricaine de la pratique clinique pour l\u2019EM\/SFC \u2013 Recommandations relatives aux examens<\/em>\u00a0<\/span>(S. ME\/CFS Clinician Coalition \u2013 Testing Recommendations<\/a>)<\/li>\n
        • Coalition am\u00e9ricaine de la pratique clinique pour l\u2019EM\/SFC \u2013 Recommandations relatives au traitement\u00a0<\/span><\/em>(S. ME\/CFS Clinician Coalition \u2013 Treatment Recommendations<\/a>)<\/li>\n
        • Coalition am\u00e9ricaine de la pratique clinique pour l\u2019EM\/SFC \u2013 Site internet (section de la prise en charge clinique)\u00a0<\/span><\/em>S.\u00a0ME\/CFS Clinician Coalition \u2013 Website (Clinical Management Section)<\/a><\/li>\n<\/ul>\n

          Webinaires<\/strong><\/p>\n

          <\/strong><\/p>\n

          \n
          • Expos\u00e9 de la D^{re<\/sup>\u00a0<\/span>Muirhead sur le diagnostic et la prise en charge de l\u2019enc\u00e9phalomy\u00e9lite myalgique (organis\u00e9 par l\u2019IALA des IRSC)\u00a0<\/span><\/em>(}\u00a0<\/span>Muirhead on ME diagnosis and management [hosted by CIHR-IMHA])<\/a><\/li>\n
          • Entretien avec les D^{r<\/sup>\u00a0<\/span>Bateman, Dre<\/sup>\u00a0<\/span>Muirhead, Dr\u00a0<\/sup>Nacul et Mme\u00a0Robertson sur le diagnostic et la prise en charge de l\u2019enc\u00e9phalomy\u00e9lite myalgique<\/em>\u00a0<\/span>(}\u00a0<\/span>Muirhead on ME diagnosis and management [hosted by CIHR-IMHA]<\/a>)<\/li>\n
          • Expos\u00e9 du D^{r<\/sup>\u00a0<\/span>Yellman sur la d\u00e9finition du malaise apr\u00e8s effort (vid\u00e9o)\u00a0<\/span><\/em>(}\u00a0<\/span>Yellman on What is Post Exertional Malaise [Video]<\/a>)<\/li>\n
          • Expos\u00e9 du D^{r<\/sup>\u00a0<\/span>Yellman sur la d\u00e9finition du malaise apr\u00e8s effort (diapositives de l<\/em>\u2018expos\u00e9)\u00a0<\/span><\/em>(}\u00a0<\/span>Yellman on What is Post Exertional Malaise [Presentation Slides])<\/a><\/li>\n
          • Dialogues au sujet de l\u2019EM\/SFC \u2013 comprendre le malaise apr\u00e8s effort<\/em>\u00a0<\/span>(Dialogues for MECFS \u2013 Understanding Post Exertional Malaise [PEM]<\/a>)<\/li>\n<\/ul>\n

            UNREST\u2014 Documentaire sur le non-repos<\/em>\u00a0<\/span>(YouTube)\u00a0<\/span>(Unrest Documentary on YouTube)<\/a><\/p>\n

            [\/et_pb_text][et_pb_divider color=”#e2e2e2″ _builder_version=”4.27.3″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_text module_id=”pacing” _builder_version=”4.27.4″ _module_preset=”default” link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″]<\/p>\n

            Ressources concernant le rythme des activit\u00e9s<\/h2>\n

            Ressources concernant le rythme des activit\u00e9s<\/strong><\/p>\n

            <\/strong><\/p>\n

            \n
            • Guide sur la gestion et le rythme des activit\u00e9s (\u00ab\u00a0pacing\u00a0\u00bb) dans les cas d\u2019EM\/SFC et de COVID-19 de longue dur\u00e9e (recherche collaborative sous la direction de MEAction et de malades)<\/em>\u00a0<\/span>(Pacing and Management Guide for MECFS and Long COVID [MEAction and Patient-Led Research Collaborative])<\/a><\/li>\n
            • Guide sur la gestion et le rythme des activit\u00e9s (\u00ab\u00a0pacing\u00a0\u00bb) pour l\u2019EM\/SFC (MEAction)\u00a0<\/span><\/em>(Pacing and Management Guide for MECFS [MEAction])<\/a><\/li>\n
            • Guide sur la gestion et le rythme des activit\u00e9s (\u00ab\u00a0pacing\u00a0\u00bb) dans les cas p\u00e9diatriques d\u2019EM\/SFC et de COVID-19 de longue dur\u00e9e (MEAction et famille de malades souffrant de COVID-19 de longue dur\u00e9e)<\/em>\u00a0<\/span>(Pediatric Pacing and Management Guide for ME\/CFS and Long COVID [MEAction and Long COVID Families])<\/a><\/li>\n
            • Comment survivre \u00e0 l\u2019\u00e9pisode asth\u00e9nique (\u00ab\u00a0crash\u00a0\u00bb) (Bateman Horne Center)<\/em>\u00a0<\/span>(Crash Survival Guide [Bateman Horne Center])<\/a><\/li>\n<\/ul>\n
              <\/ul>\n

              [\/et_pb_text][et_pb_divider color=”#e2e2e2″ _builder_version=”4.27.3″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_text module_id=”comorbidities” _builder_version=”4.27.3″ _module_preset=”default” link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″]<\/p>\n

              Conditions comorbides fr\u00e9quentes \u2013 Diagnostic et prise en charge<\/h2>\n

              Intol\u00e9rance orthostatique<\/strong><\/p>\n

              \n
              • Informations g\u00e9n\u00e9rales concernant l\u2019intol\u00e9rance orthostatique<\/em>\u00a0<\/span>General Information on Orthostatic Intolerance (OI)<\/a><\/li>\n<\/ul>\n

                Syndrome de tachycardie orthostatique posturale (STOP)<\/strong><\/p>\n

                \n
                • Bateman Horne Center \u2013 Test d\u2019inclinaison de 10 minutes de la NASA (<\/em>Bateman Horne Center \u2013 10 Minute NASA Lean Test<\/a>)<\/li>\n<\/ul>\n

                  Syndrome d\u2019activation mastocytaire (SAMA)<\/strong><\/p>\n

                  \n
                  • Bateman Horne Center \u2013 Expos\u00e9 sur le syndrome d\u2019activation mastocytaire (SAMA) (vid\u00e9o)<\/em>\u00a0<\/span>Bateman Horne Center \u2013 Presentation on MCAS [Video])<\/a><\/a><\/li>\n
                  • Bateman Horne Center \u2013 Expos\u00e9 sur le syndrome d\u2019activation mastocytaire (SAMA) (diapositives) (<\/em>Bateman Horne Center \u2013 Presentation on MCAS [slides])<\/a><\/li>\n
                  • Guide d\u2019examen complet pour le diagnostic du SAMA<\/em>\u00a0<\/span>(Guide for MCAS Diagnostic Workup<\/a>)<\/li>\n<\/ul>\n

                    Syndrome d\u2019Ehlers-Danlos et de l\u2019hypermobilit\u00e9<\/strong><\/p>\n

                    (Ressources \u00e0 venir)<\/em><\/p>\n

                    <\/ul>\n
                    <\/ul>\n

                    [\/et_pb_text][et_pb_divider color=”#e2e2e2″ _builder_version=”4.27.3″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”||0px||false|false” global_colors_info=”{}”][\/et_pb_divider][et_pb_text module_id=”special” _builder_version=”4.27.4″ _module_preset=”default” link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″]<\/p>\n

                    Consid\u00e9rations particuli\u00e8res<\/h2>\n

                    Consid\u00e9rations particuli\u00e8res<\/strong><\/strong><\/p>\n

                    \n
                    • Consid\u00e9rations relatives aux soins en clinique d\u2019urgence ou sans rendez-vous (Bateman Horne Center)<\/em>\u00a0<\/span>(Emergency or Urgent Care Considerations [Bateman Horne Center])<\/a><\/li>\n
                    • Pr\u00e9paration en vue d\u2019une op\u00e9ration chirurgicale (article de revue scientifique)<\/em>\u00a0<\/span>(Preparing for Surgery [Publication])<\/a><\/li>\n<\/ul>\n
                      <\/ul>\n
                      <\/ul>\n

                      [\/et_pb_text][et_pb_text module_id=”supporting” _builder_version=”4.27.4″ _module_preset=”default” link_text_color=”gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123″ ul_font=”|300|||||||” header_2_font=”Merriweather||||||||” header_2_text_color=”#000000″ header_2_font_size=”34px” custom_margin=”2vw||||false|false” global_colors_info=”{%22gcid-81f9ad88-9858-401f-a912-9ef6823933cf%22:%91%22link_text_color__hover%22%93,%22gcid-fea9fa74-a3a6-4bb5-9e3c-fcd8a2430123%22:%91%22link_text_color%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#247a62″]<\/p>\n

                      Assistance aux d\u00e9marches reli\u00e9es aux demandes d\u2019accommodement et aux programmes d\u2019assistance invalidit\u00e9<\/h2>\n

                      Lettre de nos sp\u00e9cialistes<\/strong>\u00a0<\/span>(A letter from our experts<\/a>)<\/p>\n

                      \u00c9valuation des heures d\u2019activit\u00e9 en position debout et de la capacit\u00e9 fonctionnelle<\/strong>\u00a0<\/span>(Assessing Hours of Upright Activity and Level of Function<\/a>)<\/p>\n

                      Documenter l\u2019invalidit\u00e9 caus\u00e9e par l\u2019enc\u00e9phalomy\u00e9lite myalgique (<\/strong>Documenting Disability in ME<\/a>)<\/p>\n

                      Examens \u00e0 l\u2019appui d\u2019une demande d\u2019aide pour invalidit\u00e9 (pages 13\u201317)\u00a0<\/span><\/strong>(Tests to Support Disability Application [pages 13-17])<\/a><\/p>\n

                      Documentation m\u00e9dicale de l\u2019invalidit\u00e9 caus\u00e9e par l\u2019enc\u00e9phalomy\u00e9lite myalgique\u00a0<\/span><\/strong>(Medically Documenting Disability in ME cases<\/a><\/p>\n

                      [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

                      \n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

                      \n\t\t\t\t\t

                      \n\t\t\t\t\t\t\t\t

                      \n\t\t\t\t\t\t\t\t\t
                      1. \n\t\t\t\t\t\t\t\t\t\t\t\t\t \n\t\t\t\t\t\t\t\t\t\t\t\t\t \tHome<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t <\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t \n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<\/ol>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>RESOURCESRessources cliniques Cette section est destin\u00e9e \u00e0 offrir aux g\u00e9n\u00e9ralistes une compilation de renseignements de consultation rapide et facile, pour am\u00e9liorer leur compr\u00e9hension des notions entourant le diagnostic et la prise en charge de l\u2019enc\u00e9phalomy\u00e9lite myalgique et des conditions comorbides, et pour\u2026 Read More »<\/a><\/p>\n","protected":false},"author":68,"featured_media":0,"parent":1561,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1697","page","type-page","status-publish","hentry"],"yoast_head":"\n